Abstract | PURPOSE OF REVIEW: Emerging data suggest that biomarkers of brain injury have potential utility as diagnostic, prognostic, and therapeutic adjuncts in the setting of traumatic and ischemic brain injury. Two approaches are being used, namely, assessing markers of structural damage and quantifying mediators of the cellular, biochemical, or molecular cascades in secondary injury or repair. Novel proteomic, multiplex, and lipidomic methods are also being applied. RECENT FINDINGS: SUMMARY: Multifaceted cellular, biochemical, and molecular monitoring of proteins and lipids is logical as an adjunct to guiding therapies and improving outcomes in traumatic and ischemic brain injury and we appear to be on the verge of a breakthrough with the use of these markers as diagnostic, prognostic, and monitoring adjuncts, in neurointensive care.
|
Authors | Patrick M Kochanek, Rachel P Berger, Hülya Bayir, Amy K Wagner, Larry W Jenkins, Robert S B Clark |
Journal | Current opinion in critical care
(Curr Opin Crit Care)
Vol. 14
Issue 2
Pg. 135-41
(Apr 2008)
ISSN: 1070-5295 [Print] United States |
PMID | 18388674
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Biomarkers
- Myelin Basic Protein
- Nerve Growth Factors
- S100 Calcium Binding Protein beta Subunit
- S100 Proteins
- S100B protein, human
- Phosphopyruvate Hydratase
|
Topics |
- Biomarkers
- Brain Injuries
(diagnosis, physiopathology)
- Brain Ischemia
(diagnosis, physiopathology)
- Decision Making
- Humans
- Inflammation
- Myelin Basic Protein
(analysis)
- Nerve Growth Factors
(analysis)
- Oxidative Stress
- Phosphopyruvate Hydratase
(analysis)
- Prognosis
- Proteomics
- S100 Calcium Binding Protein beta Subunit
- S100 Proteins
(analysis)
|